Corinne Rekart
Psychiatric/Mental Health · Portland, ORNPI 1598895013
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,383 and has fallen 50.5% since, to $685 in 2025. Among psychiatric/mental health clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $23.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$707
- Alkermes, Inc.$602
- AbbVie$403
- Johnson & Johnson$349
- Vanda Pharmaceuticals Inc.$339
- Takeda Pharmaceuticals U.S.A., Inc.$244
- plus $909 from 11 others
What the payments were for
- Food & beverage$3,553100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 24 | $707 |
| Alkermes, Inc. | 21 | $602 |
| AbbVie | 15 | $403 |
| Johnson & Johnson | 11 | $349 |
| Vanda Pharmaceuticals Inc. | 12 | $339 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $244 |
| Bausch Health US, LLC | 14 | $197 |
| Otsuka America Pharmaceutical, Inc. | 9 | $179 |
| Sunovion Pharmaceuticals Inc. | 10 | $170 |
| Corium, LLC | 10 | $131 |
| Lundbeck LLC | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Ironshore Pharmaceuticals Inc. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,553 in reported general payments places this provider in the 95th percentile of 540 psychiatric/mental health providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 18 | $1,559 |
| Paliperidone ErPaliperidone | 12 | $1,143 |
| Olanzapine | 22 | $385 |
| Duloxetine Hcl | 14 | $366 |
| Gabapentin | 26 | $356 |
| Atorvastatin Calcium | 40 | $349 |
| Prazosin Hcl | 16 | $327 |
| Olanzapine OdtOlanzapine | 11 | $306 |
| Clonazepam | 17 | $304 |
| Lamotrigine | 27 | $298 |
| Haloperidol | 21 | $297 |
| Lorazepam | 28 | $263 |
| Quetiapine Fumarate | 13 | $261 |
| Trazodone Hcl | 25 | $261 |
| Hydroxyzine Pamoate | 27 | $229 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Portland
- Tina Matthews-HayesPortland$787K
- Johnni CanslerPortland$529K
- Jill CarterPortland$416K
- Michelle VoegelsPortland$29K
- Kalesha JonesPortland$2K
- Tamara JohnsonPortland$2K
- Orawan LaochumnanvanitPortland$2K
- Samantha LauPortland$2K
- Rebecca BermanPortland$2K
- Tara CandelaPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.